AAAAAA
Results: 1-25/33
Authors:
Lijnen, HR
Citation: Hr. Lijnen, Gene targeting in hemostasis. Alpha(2)-antiplasmin, FRONT BIOSC, 6, 2001, pp. D239-D247
Authors:
Silence, J
Lupu, F
Collen, D
Lijnen, HR
Citation: J. Silence et al., Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation, ART THROM V, 21(9), 2001, pp. 1440-1445
Authors:
Dewerchin, M
Collen, D
Lijnen, HR
Citation: M. Dewerchin et al., Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha(2)-antiplasmin and PAI-1, THROMB HAEM, 86(2), 2001, pp. 640-646
Authors:
Lijnen, HR
Citation: Hr. Lijnen, Plasmin and matrix metalloproteinases in vascular remodeling, THROMB HAEM, 86(1), 2001, pp. 324-333
Authors:
Lijnen, HR
Maquoi, E
Holvoet, P
Mertens, A
Lupu, F
Morange, P
Alessi, MC
Juhan-Vague, I
Citation: Hr. Lijnen et al., Adipose tissue expression of gelatinases in mouse models of obesity, THROMB HAEM, 85(6), 2001, pp. 1111-1116
Authors:
Lijnen, HR
Van Hoef, BT
Collen, D
Citation: Hr. Lijnen et al., Inactivation of the serpin alpha(2)-antiplasmin by stromelysin-1, BBA-PROT ST, 1547(2), 2001, pp. 206-213
Authors:
Lijnen, HR
Bloemmen, F
Vereecken, A
Collen, D
Citation: Hr. Lijnen et al., Enzyme-linked immunosorbent assay for the specific detection of angiostatin-like plasminogen moieties in biological samples, THROMB RES, 102(1), 2001, pp. 53-59
Authors:
Ugwu, F
Lemmens, G
Collen, D
Lijnen, HR
Citation: F. Ugwu et al., Matrix metalloproteinase deficiencies do not impair cell-associated fibrinolytic activity, THROMB RES, 102(1), 2001, pp. 61-69
Authors:
Arza, B
De Maeyer, M
Felez, J
Collen, D
Lijnen, HR
Citation: B. Arza et al., Critical role of glutamic acid 202 in the enzymatic activity of stromelysin-1 (MMP-3), EUR J BIOCH, 268(3), 2001, pp. 826-831
Authors:
Kawasaki, T
Dewerchin, H
Lijnen, HR
Vreys, I
Vermylen, J
Hoylaerts, MF
Citation: T. Kawasaki et al., Mouse carotid artery ligation induces platelet-leukocyte-dependent luminalfibrin, required for neointima development, CIRCUL RES, 88(2), 2001, pp. 159-166
Authors:
Lijnen, HR
Ugwu, F
Maquoi, E
Lemmens, G
Van Hoef, B
Dewerchin, M
Collen, D
Citation: Hr. Lijnen et al., Vascular and cellular proteolytic activity in mice with alpha(2)-antiplasmin gene inactivation, FIBRINOL PR, 14(5), 2000, pp. 322-326
Authors:
Lijnen, HR
Van Hoef, B
Roelants, I
Collen, D
Citation: Hr. Lijnen et al., Fibrin(ogen) degradation by a 24k-endopeptidase from a Chryseobacterium Sp., FIBRINOL PR, 14(4), 2000, pp. 247-252
Authors:
Collen, D
Lijnen, HR
Citation: D. Collen et Hr. Lijnen, Recent developments in thrombolytic therapy, FIBRINOL PR, 14(2-3), 2000, pp. 66-72
Authors:
Lijnen, HR
Citation: Hr. Lijnen, Molecular interactions between the plasminogen/plasmin and matrix metalloproteinase systems, FIBRINOL PR, 14(2-3), 2000, pp. 175-181
Authors:
Lijnen, HR
Van Hoef, B
Dewerchin, M
Collen, D
Citation: Hr. Lijnen et al., alpha(2)-antiplasmin gene deficiency in mice does not affect neointima formation after vascular injury, ART THROM V, 20(6), 2000, pp. 1488-1492
Authors:
Morange, PE
Lijnen, HR
Alessi, MC
Kopp, F
Collen, D
Juhan-Vague, I
Citation: Pe. Morange et al., Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity, ART THROM V, 20(4), 2000, pp. 1150-1154
Authors:
Lijnen, HR
Collen, D
Citation: Hr. Lijnen et D. Collen, Molecular basis of thrombolytic therapy, J NUCL CARD, 7(4), 2000, pp. 373-381
Authors:
Arza, B
Felez, J
Fabregas, P
Laroche, Y
Collen, D
Lijnen, HR
Citation: B. Arza et al., Plasminogen binding properties of macrophage inflammatory protein (MIP)-2 alpha, THROMB HAEM, 84(1), 2000, pp. 71-77
Authors:
Lijnen, HR
Lupu, F
Collen, D
Le Naour, F
Boucheix, C
Citation: Hr. Lijnen et al., CD9 gene deficiency does not affect smooth muscle cell migration and neointima formation after vascular injury in mice, THROMB HAEM, 83(6), 2000, pp. 956-961
Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3)
Authors:
Lijnen, HR
Arza, B
Van Hoef, B
Collen, D
Declerck, PJ
Citation: Hr. Lijnen et al., Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3), J BIOL CHEM, 275(48), 2000, pp. 37645-37650
Authors:
Arza, B
Hoylaerts, MF
Felez, J
Collen, D
Lijnen, HR
Citation: B. Arza et al., Prostromelysin-1 (proMMP-3) stimulates plasminogen activation by tissue-type plasminogen activator, EUR J BIOCH, 267(21), 2000, pp. 6378-6384
Authors:
Kawasaki, T
Dewerchin, M
Lijnen, HR
Vermylen, J
Hoylaerts, MF
Citation: T. Kawasaki et al., Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysisduring acute arterial thrombosis in mice, BLOOD, 96(1), 2000, pp. 153-160
Specific proteolysis of human plasminogen by a 24 kDa endopeptidase from anovel Chryseobacterium sp.
Authors:
Lijnen, HR
Van Hoef, B
Ugwu, F
Collen, D
Roelants, I
Citation: Hr. Lijnen et al., Specific proteolysis of human plasminogen by a 24 kDa endopeptidase from anovel Chryseobacterium sp., BIOCHEM, 39(2), 2000, pp. 479-488
Authors:
Lijnen, HR
Van Hoef, B
Vanlinthout, I
Verstreken, M
Rio, MC
Collen, D
Citation: Hr. Lijnen et al., Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivation, ART THROM V, 19(12), 1999, pp. 2863-2870
Authors:
Ugwu, F
Lemmens, G
Collen, D
Lijnen, HR
Citation: F. Ugwu et al., Modulation of cell-associated plasminogen activation by stromelysin-1 (MMP-3), THROMB HAEM, 82(3), 1999, pp. 1127-1131